This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:patients:protocol_overview [06.07.2011] – [Introduction to the Marshall Protocol] paulalbert | home:patients:protocol_overview [08.19.2018] – [Read more] sallieq | ||
---|---|---|---|
Line 7: | Line 7: | ||
The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and almost 100% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases. | The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and almost 100% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases. | ||
- | At its essence, the MP involves | + | At its essence, the MP involves |
- | * take 4 doses of olmesartan (Benicar) per day | + | * take a minimum of four doses of olmesartan (Benicar) per day |
- | * take varying combinations of pulsed, low doses of specific bacteriostatic antibiotics | + | |
* wean off any immunosuppressive or potentially immunosuppressive [[home: | * wean off any immunosuppressive or potentially immunosuppressive [[home: | ||
- | * avoid the consumption of vitamin D, as well as certain other immunosuppressive [[home: | + | * avoid the consumption of vitamin D, as well as certain other immunosuppressive [[home: |
+ | * avoid as far as possible stress and environmental immune suppression | ||
+ | * [[home: | ||
- | The objective | + | Many MP patients also take varying combinations |
- | Treatment on the MP requires a [[home: | + | The objective of the MP is to safely activate a [[home: |
+ | |||
+ | Treatment on the MP requires a [[home: | ||
The MP is to be administered only by a [[home: | The MP is to be administered only by a [[home: | ||
Line 21: | Line 24: | ||
===== Medications used ===== | ===== Medications used ===== | ||
+ | |||
+ | The document [[home: | ||
+ | |||
+ | Without active participation of patients on MarshallProtocol.com site, Autoimmunity Research Foundation does not support or license the public use of this therapy. | ||
- | {{section>: | ||
Line 82: | Line 88: | ||
* [[home: | * [[home: | ||
* [[home: | * [[home: | ||
+ | * [[home: | ||
- | |||
- | |||
- | {{tag> | ||
Line 92: | Line 96: | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | OVERSEER | ||
+ | {{tag> | ||
* Legacy content | * Legacy content |